DE69123795D1 - Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau - Google Patents
Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im DickdarmniveauInfo
- Publication number
- DE69123795D1 DE69123795D1 DE69123795T DE69123795T DE69123795D1 DE 69123795 D1 DE69123795 D1 DE 69123795D1 DE 69123795 T DE69123795 T DE 69123795T DE 69123795 T DE69123795 T DE 69123795T DE 69123795 D1 DE69123795 D1 DE 69123795D1
- Authority
- DE
- Germany
- Prior art keywords
- rectal administration
- pharmaceutical composition
- active ingredients
- medicinal effects
- topical medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000001072 colon Anatomy 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 230000007721 medicinal effect Effects 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 229940126702 topical medication Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT02110490A IT1243379B (it) | 1990-07-27 | 1990-07-27 | Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69123795D1 true DE69123795D1 (de) | 1997-02-06 |
DE69123795T2 DE69123795T2 (de) | 1997-07-10 |
DE69123795T3 DE69123795T3 (de) | 2001-07-12 |
Family
ID=11176813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69123795T Expired - Lifetime DE69123795T3 (de) | 1990-07-27 | 1991-06-14 | Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau |
Country Status (10)
Country | Link |
---|---|
US (1) | US5449520A (de) |
EP (1) | EP0468555B2 (de) |
JP (1) | JP3291301B2 (de) |
AT (1) | ATE146674T1 (de) |
CA (1) | CA2044676C (de) |
DE (1) | DE69123795T3 (de) |
DK (1) | DK0468555T4 (de) |
ES (1) | ES2097787T5 (de) |
GR (2) | GR3022790T3 (de) |
IT (1) | IT1243379B (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9414699D0 (en) * | 1994-07-21 | 1994-09-07 | Slagel David | Aqueous foamable composition |
DE4446891A1 (de) * | 1994-12-27 | 1996-07-04 | Falk Pharma Gmbh | Stabile wäßrige Budesonid-Lösung |
WO1996023507A1 (fr) * | 1995-02-02 | 1996-08-08 | Chugai Seiyaku Kabushiki Kaisha | Preparation de sucralfate |
EP0835098B1 (de) | 1995-06-27 | 2002-09-04 | Boehringer Ingelheim Pharma KG | Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole |
IT1277663B1 (it) * | 1995-09-28 | 1997-11-11 | Crinos Industria Farmaco | Sospensioni acquose stabili di mesalazina per uso topico |
US7135191B2 (en) * | 1997-09-04 | 2006-11-14 | Zsolt Istvan Hertelendy | Urogenital or anorectal transmucosal vaccine delivery system |
US6239120B1 (en) | 1998-03-17 | 2001-05-29 | Pharmalink Ab | Method and means for treating glomerulonephritis |
US6326364B1 (en) * | 1999-02-08 | 2001-12-04 | Cedars-Sinai Medical Center | Use of 5-aminosalicylates as antimicrobial agents |
DE19941933A1 (de) * | 1999-09-03 | 2001-03-15 | Cognis Deutschland Gmbh | Tensidsysteme |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
EP1312368A1 (de) * | 2001-11-19 | 2003-05-21 | Dr. Falk Pharma Gmbh | Zusammensetzungen enthaltend Mesalazin zur Behandlung von entzündlichen Darmerkrankungen |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
KR101108439B1 (ko) | 2002-10-25 | 2012-01-31 | 포믹스 리미티드 | 화장료 및 약제용 거품제 |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US9668972B2 (en) * | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
JP2005015365A (ja) * | 2003-06-25 | 2005-01-20 | Koike Kagaku Kk | エアゾール型洗浄消毒剤 |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
AU2007207116B2 (en) * | 2006-01-19 | 2012-08-02 | Disphar International B.V. | Foam-forming composition |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US7645801B2 (en) | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
BR112012012315A2 (pt) | 2009-11-23 | 2018-10-16 | Cipla Ltd | composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou anus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de silicone e dispensador para composição farmacêutica |
MX2012005883A (es) | 2009-11-23 | 2012-10-09 | Cipla Ltd | Composicion topica en espuma. |
US8174881B2 (en) | 2009-11-24 | 2012-05-08 | Micron Technology, Inc. | Techniques for reducing disturbance in a semiconductor device |
EP3115037B1 (de) | 2015-07-08 | 2018-08-15 | Dr. Falk Pharma Gmbh | Pharmazeutische formulierung zur behandlung von entzündlichen veränderungen des enddarms |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
BR112019012122A2 (pt) * | 2016-12-16 | 2019-11-05 | Ferring Bv | formulações de espuma retais |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0015334B1 (de) * | 1977-08-04 | 1982-05-19 | J.B. Tillott Limited | Pfefferminzöl oder dessen aktive Bestandteile enthaltende Carminativa |
JPS5921613A (ja) * | 1982-07-28 | 1984-02-03 | Takeda Chem Ind Ltd | 直腸投与製剤 |
US4664256A (en) * | 1983-09-06 | 1987-05-12 | Farmaceutisk Laboratorium Ferring A/S | Packaged stable enema solution or suspension containing 5-aminosalicyclic acid |
US4609403A (en) * | 1984-03-12 | 1986-09-02 | Warner-Lambert Company | Foam soft gelatin capsules and their method of manufacture |
US4814183A (en) * | 1987-08-31 | 1989-03-21 | Merck & Co., Inc. | Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins |
US5206268A (en) * | 1988-08-16 | 1993-04-27 | Burroughs Wellcome Co. | Medicaments |
GB8909559D0 (en) * | 1989-04-26 | 1989-06-14 | Smith Kline French Lab | Pharmaceutical compositions |
FR2647344B1 (fr) * | 1989-05-25 | 1995-06-02 | Physiopharm Sarl | Mousse aerosol a usage rectal |
-
1990
- 1990-07-27 IT IT02110490A patent/IT1243379B/it active IP Right Grant
-
1991
- 1991-06-14 DK DK91201485T patent/DK0468555T4/da active
- 1991-06-14 CA CA002044676A patent/CA2044676C/en not_active Expired - Lifetime
- 1991-06-14 ES ES91201485T patent/ES2097787T5/es not_active Expired - Lifetime
- 1991-06-14 AT AT91201485T patent/ATE146674T1/de not_active IP Right Cessation
- 1991-06-14 EP EP91201485A patent/EP0468555B2/de not_active Expired - Lifetime
- 1991-06-14 DE DE69123795T patent/DE69123795T3/de not_active Expired - Lifetime
- 1991-06-26 JP JP18059991A patent/JP3291301B2/ja not_active Expired - Lifetime
-
1993
- 1993-10-01 US US08/130,624 patent/US5449520A/en not_active Expired - Lifetime
-
1997
- 1997-03-11 GR GR970400474T patent/GR3022790T3/el unknown
-
2001
- 2001-03-23 GR GR20010400479T patent/GR3035634T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0468555T3 (da) | 1997-06-09 |
ATE146674T1 (de) | 1997-01-15 |
GR3035634T3 (en) | 2001-06-29 |
IT9021104A1 (it) | 1992-01-27 |
EP0468555A1 (de) | 1992-01-29 |
JPH04234315A (ja) | 1992-08-24 |
DE69123795T2 (de) | 1997-07-10 |
EP0468555B1 (de) | 1996-12-27 |
IT1243379B (it) | 1994-06-10 |
US5449520A (en) | 1995-09-12 |
DK0468555T4 (da) | 2001-04-02 |
CA2044676A1 (en) | 1992-01-28 |
JP3291301B2 (ja) | 2002-06-10 |
ES2097787T3 (es) | 1997-04-16 |
GR3022790T3 (en) | 1997-06-30 |
CA2044676C (en) | 2003-04-01 |
ES2097787T5 (es) | 2001-04-01 |
EP0468555B2 (de) | 2001-02-07 |
DE69123795T3 (de) | 2001-07-12 |
IT9021104A0 (it) | 1990-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69123795D1 (de) | Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau | |
IT7928464A0 (it) | Composizione farmaceutica avente attivita' antitumorale. | |
DE19375061I2 (de) | Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung. | |
ITRM910696A1 (it) | Composizioni farmaceutiche per l'applicazione per via nasale. | |
DE68919146D1 (de) | Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen. | |
FI941771A (fi) | Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten | |
IT8323205A0 (it) | Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene. | |
DE3768419D1 (de) | Pharmazeutische zusammensetzungen mit antineoplastischer wirkung. | |
ITMI922603A1 (it) | Composizioni farmaceutiche comprendenti un farmaco, una sostanza polimerica reticolata, un olio ed un agente tensioattivo | |
DE69928815D1 (de) | Dosierungsform mit flüssiger formulierung | |
DE69322251D1 (de) | Medizinische zusammensetzung | |
ATE97001T1 (de) | Topisch anzuwendende defibrotid enthaltende arzneizubereitungen. | |
DE3576505D1 (de) | 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen. | |
DK0453603T3 (da) | Piroxicamholdige farmaceutiske præparater til topisk anvendelse | |
IT8021550A0 (it) | Derivati adenosinici ad attivita'antinfiammatoria ed analgesica e composizioni terapeutiche che licontengono come principio attivo. | |
DE3578597D1 (de) | 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE132877T1 (de) | Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung | |
FR2677250B1 (fr) | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique. | |
DE69123190D1 (de) | Hirudin enthaltende orale Arzneimittel | |
DE68907609D1 (de) | Arzneimittelzusammensetzung. | |
DE3484155D1 (de) | Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216. | |
IT8621925A0 (it) | Composizioni farmaceutiche adattivita' antineoplastica. | |
IT8622051A0 (it) | Composizioni farmaceutiche adattivita' cicatrizzante. | |
KR960021045A (ko) | 페루릭산을 포함하는 b형 간염 치료제 | |
IT7825476A0 (it) | Derivati dell'encefalina ad azione terapeutica, procedimento per laloro fabbricazione e relative composizioni farmaceutiche. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings |